Perrigo Co PLC (id:9112 PRGO)
27.08 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/22/2024 1:15:26 AM)
Exchange closed, opens in 8 hours 14 minutes
About Perrigo Co PLC
Market Capitalization 3.67B
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
| Headquarters (address) |
The Sharp Building Dublin D02 TY74 Ireland |
| Phone | 353 1 709 4000 |
| Website | https://www.perrigo.com |
| Employees | 9,140 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | PRGO |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 23.89 - 34.60 |
| Market Capitalization | 3.67B |
| Dividend yield forward | 4.10 % |
| Dividend yield forward Ireland (ID:161, base:38) | 5.45 % |
| P/E trailing | 2,818.00 |
| P/E forward | 8.62 |
| Price/Sale | 0.835 |
| Price/Book | 0.804 |
| Beta | 0.484 |
| EPS | -1.07 |
| EPS Ireland (ID:161, base:53) | 2.57 |
Dividend growth streak
Perrigo Co PLC has raised their dividend 20.00 years in a row. This is above the 4.478497 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Perrigo Co PLC has raised their dividend 4.10 years in a row. This is below the 41125.058700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Perrigo Co PLC has raised their dividend 6.66 years in a row. This is below the 24.014500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Perrigo Co PLC has raised their dividend 7.52 years in a row. This is below the 12.586200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Perrigo Co PLC has raised their dividend 11.43 years in a row. This is above the 10.156100 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Perrigo Co PLC has raised their dividend 10,950.00 years in a row. This is above the 146.971600 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
Perrigo Co PLC has raised their dividend 20.00 years in a row. This is above the 4.478497 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Perrigo Co PLC has raised their dividend 4.10 years in a row. This is below the 41125.058700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Perrigo Co PLC has raised their dividend 6.66 years in a row. This is below the 24.014500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Perrigo Co PLC has raised their dividend 7.52 years in a row. This is below the 12.586200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Perrigo Co PLC has raised their dividend 11.43 years in a row. This is above the 10.156100 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Perrigo Co PLC has raised their dividend 10,950.00 years in a row. This is above the 146.971600 year average in the 'Drug Manufacturers Specialty & Generic' industry